In the field of dental implantology, "Made in Germany" is often associated with precision engineering and strict quality control. Originating from Berlin, Germany, the Meoplant® implant system focuses on the R&D and supply of high‑quality implant systems. With German origin, multiple international certifications, and patented technology combinations, it provides systematic implant restoration solutions for dental clinicians worldwide.
German Origin and Full‑Process Quality Control
Headquartered at Marscher Straße in Berlin, Germany, Meoplant® implements German DIN standards throughout raw material procurement, R&D, and manufacturing. The main body is made of premium grade 4 cold‑worked titanium, which, after cold working, offers good biocompatibility and high mechanical strength, effectively reducing the probability of galvanic corrosion at the implant‑abutment connection and ensuring long‑term safety. The product line covers various diameters and lengths, suitable for a wide range of clinical indications.
Authoritative Certifications
Meoplant® has obtained multiple certifications, including U.S. FDA, EU CE, China NMPA, German DQS, IQNet, and GS1 Germany. Among them, DQS certification covers the entire product life cycle of R&D, production, and quality inspection, and is an important evaluation system for German industrial quality control. These certifications provide compliance support for the brand's global market entry and constitute a transparent endorsement of product quality.
Overview of Four Core Technologies
1. MEOBAND® Patented Surface Treatment: Through zirconia blasting and acid etching, it forms a micro‑rough surface with an Ra value of approximately 1.4 μm, which facilitates osteoblast attachment and proliferation. Clinical observations indicate that this technology contributes to early osseointegration and long‑term stability. Combined with ultra‑clean cleaning and hydrophilic surface treatment processes, it maintains the biological activity of the implant surface, slows titanium oxidation, and is suitable for patients with elevated blood glucose, blood pressure, or underlying diseases.
2. FEP™ Fluid and Gas Evacuation Technology: The implant features three thread grooves extending from the apex to the shoulder. During insertion, they can vent enclosed air and contaminated fluids from the osteotomy, reduce intraosseous pressure, and create a more stable environment for osseointegration.
3. CrDcom™ Crest Decompression Technology: During placement, it controllably expels bacteria‑containing saliva and excess blood while preserving the blood clot, promoting bone regeneration.
4. pH‑Osseo™ Bone Chip Collection Technology: During osteotomy preparation, it collects autogenous bone chips containing active factors and delivers them to the implant surface, using the patient's own bone tissue to stimulate healing.
The four technologies work synergistically to form a comprehensive technical system covering placement, healing, and bone regeneration stages.
Brand Service Philosophy
Meoplant® values daily collaboration with clinicians through education, technical support, and supply chain management, establishing long‑term partnerships. The brand is dedicated to dental implantology, aesthetic restoration, and CAD/CAM digital fields, continuously optimising products and workflows.
China Market Presence
Currently, Meoplant® has entered the Chinese market and collaborates with domestic dental institutions to provide German‑origin implant restoration services for edentulous patients. The brand will continue to be driven by technological innovation and clinical needs, improving products and services.